← FDA Drug Approvals (Drugs@FDA)
CETRORELIX ACETATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS INC · Approved 2022-08-12
Drug application
- FDA Application #
ANDA215737- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CETRORELIX ACETATE
- Generic name
- CETRORELIX ACETATE
- Active ingredients
- CETRORELIX ACETATE
- Dosage form
- POWDER
- Route
- SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- TEVA PHARMS INC
- Manufacturer
- Teva Pharmaceuticals, Inc.
- First approval
- 2022-08-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown